Akerna Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of share based compensation stock warrant activity

	Exercise Price		Expiration Date	Balance as of December 31, 2022		Issued		Exercised		Expired		Balance as of March 31, 2023
2019 Public Warrants (1)	$	230.00	6/19/2024		5,813,804		—		—		—		5,813,804
2022 Unit Offering
Common Warrants (2)	$	4.60	6/29/2027		43,478,261		—		—		—		43,478,261
Underwriter Warrants (2)	$	4.60	6/29/2027		2,173,913		—		—		—		2,173,913
					51,465,978		—		—		—		51,465,978

(1) The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.

(2) The Common Warrants and Underwriter Warrants are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.88 per share or a ratio of 20 warrants for one share of Common Stock.